However, restricting the authorisation of 3′-SL sodium salt produced with derivative strains of E. coli BL21(DE3) and the reference to the scientific studies and data contained in the applicant’s file for the sole use by them does not prevent subsequent applicants from applying for an authorisation to place on the market the same novel food provided that their application is based on legally obtained information supporting such an authorisation.
Recital 13, Regulation (EU) 2023/113
In forcesince 16 Jan 2023